article thumbnail

The Mylan EpiPen Debacle: How Tremendous Greed Can Lead to the Demise of a Leader

N2Growth Blog

Through shrewd marketing efforts, failed competitors and helpful legislation (which requires its availability at public schools), Mylan has cornered the market on this allergy medication. ” “The reality is and the brand pharmaceutical market, this isn’t an EpiPen issue. This isn’t a Mylan issue.

article thumbnail

Blockchain Could Make the Insurance Industry Much More Transparent

Harvard Business Review

This gap between insurers and customers can be widened into a gulf by trust brokers, who dominate the top-heavy insurance brokerage market and benefit from its opacity and byzantine operating standards. In 2015 these top three players generated 48% of the revenues among the top 50 brokers in the U.S.

article thumbnail

6 Reasons Platforms Fail

Harvard Business Review

For years Apple’s market penetration hung in the single digits. Google Android quickly lost market share to the new versions. But by early 2015 they stopped accepting new submissions to their open market and discontinued their API support for external developers. Failure to launch the right side.